Premium
P1‐512: INCIDENCE OF MILD NEUROCOGNITIVE DISORDERS AND DEMENTIA IN ELDERLY ITALIANS WITH SELF‐REPORTED HEARING DISABILITY: RESULTS FROM THE INVECE.AB STUDY
Author(s) -
Vaccaro Roberta,
Zaccaria Daniele,
Colombo Mauro,
Rolandi Elena,
Abbondanza Simona,
Guaita Antonio
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.1117
Subject(s) - hearing loss , neurocognitive , medicine , dementia , audiology , incidence (geometry) , presbycusis , logistic regression , population , cognition , psychiatry , physics , disease , environmental health , optics
of real world tasks with patients with Alzheimer’s disease (AD) in Brazil. Methods: Cultural adaptation of EFPT to Brazilian Portuguese. The reliability and validity studies were performed with three groups of elderly: controls, mild AD and moderate AD. This study examines instrument stability, an internal consistency (Cronbach’s alpha), a construct and criterion validity, and precision analyzes. Results: The sample consisted of 83 participants aged 60 years and over, divided into three groups: control, mild AD and moderate AD. The inter-examiner reliability was high (ICC 1⁄4 0.985), with high internal consistency (Cronbach a1⁄4 0.967). There was a strong correlation between EFPT-Br Total and DAFS-BR (r 1⁄4 -0.762), weak to moderate correlation with a cognitive battery and moderate to strong correlation with the functional battery. We performed the calculation of the ROC multiclass area under the curve of 0.8933, a score suggested to differentiate the groups: less than 8 for controls; between 9 and 27 for mild AD; and above 28 for moderate AD, to discriminate groups. Conclusions: EFPTBR is a valid test with satisfactory psychometric parameters to discriminate healthy patients with mild AD and moderate AD in performing instrumental tasks. The test provides consistent information to assist in understanding the performance of AD patients in carrying out more autonomous and safe daily life activities.